Rutgers Receives $10 Million Pledge to Advance Treatment of Cancer Patients (IMAGE)

Rutgers University

Rutgers Receives $10 Million Pledge to Advance Treatment of Cancer Patients

Caption

From left, Shridar Ganesan, medical oncologist, Rutgers Cancer Institute of New Jersey; Andrew Brooks, chief operating officer, RUCDR Infinite Biologics; Robert DiPaola, director, Rutgers Cancer Institute of New Jersey; Jay Tischfield, chief executive officer, RUCDR Infinite Biologics; and Linda Brzustowicz, professor and chair, Department of Genetics, School of Arts and Sciences.

Credit

Nick Romanenko, Rutgers University

Usage Restrictions

Permission is granted to reproduce the image in connection with news coverage of this story. All other rights are reserved.

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.